Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been described. We report a new case of YEL-AVD. Given the potential risks associated with the vaccine, physicians should consider vaccination only for patients truly at risk for exposure to yellow fever, especially for primovaccination.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1708-8305.2008.00209.x | DOI Listing |
Publication Analysis
Top Keywords
yellow fever
12
viscerotropic disease
8
yellow
4
yellow fever-associated
4
fever-associated viscerotropic
4
disease barcelona
4
barcelona spain
4
spain yellow
4
fever vaccine
4
vaccine live
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!